vidarabine has been researched along with Pancytopenia in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (15.38) | 18.2507 |
2000's | 6 (46.15) | 29.6817 |
2010's | 3 (23.08) | 24.3611 |
2020's | 2 (15.38) | 2.80 |
Authors | Studies |
---|---|
Atanackovic, D; Bukhari, A; Dahiya, S; Gahres, N; Gottlieb, D; Hardy, NM; Holtzman, NG; Kansagra, AJ; Kim, DW; Kocoglu, MH; Law, JY; Lee, ST; Lutfi, F; Matsumoto, LR; Mohindra, P; Molitoris, J; Mustafa Ali, M; Rapoport, AP; Ruehle, K; Samanta, S; Yan, J; Yared, JA | 1 |
Abedi, M; Hoeg, RT; Jonas, BA; Krishnan, R; Moskoff, BN; Rosenberg, AS; Tenold, ME; Tuscano, JM | 1 |
Burger, J; Ferrajoli, A; Keating, MJ; Lerner, S; O'Brien, S; Strati, P; Tam, C; Wierda, W | 1 |
Boubaya, M; Choquet, S; Delmer, A; Dupuis, J; Le Gouill, S; Leblond, V; Levy, V; Ouzegdouh, M; Pégourié-Bandelier, B; Souchet, L; Tamburini, J; Tournilhac, O; Vargaftig, J | 1 |
Brass, D; Cunningham, J; Gelly, K; Groves, M; MacCallum, S; Sales, M; Tauro, S | 1 |
Carney, D; Gill, S; Januszewicz, H; Prince, HM; Ritchie, D; Seymour, JF; Westerman, D; Wolf, M | 1 |
Glasmacher, A; Gorschlüter, M; Mey, U; Pralle, H; Schmidt-Wolf, I; Strehl, J; Ziske, C | 1 |
De Braekeleer, M; Herry, A; Le Bris, MJ; Morel, F; Morice, P | 1 |
Blumberg, N; Fenton, P; Horan, JT; Liesveld, JL; Walters, MC | 1 |
Catovsky, D; Glynne, P; Hamblin, M; Matthey, F; Mehta, J; Middleton, G; Powles, R; Prendiville, J; Singhal, S; Treleaven, J; Zomas, A | 1 |
Azaceta, G; Gutierrez, M; Palomera, L; Soria, J; Varo, MJ | 1 |
Baccarani, M; Bertone, A; Bucalossi, A; De Vivo, A; Gobbi, M; Lauria, F; Marin, L; Mazza, P; Michelutti, A; Michieli, M; Pierri, I; Pricolo, G; Raspadori, D; Russo, D; Zaccaria, A; Zuffa, E | 1 |
Egerer, G; Ho, AD; Sauerland, K | 1 |
2 review(s) available for vidarabine and Pancytopenia
Article | Year |
---|---|
Advances in the treatment of hairy-cell leukaemia.
Topics: Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD; Antigens, Differentiation, B-Lymphocyte; Antineoplastic Agents; Cell Adhesion Molecules; Cladribine; Humans; Interferon-alpha; Lectins; Leukemia, Hairy Cell; Neoplasm, Residual; Neoplasms, Second Primary; Pancytopenia; Pentostatin; Receptors, Interleukin-2; Rituximab; Sialic Acid Binding Ig-like Lectin 2; Spleen; Splenectomy; Splenomegaly; Treatment Outcome; Vidarabine | 2003 |
Trisomy 15 as the sole abnormality in myelodysplastic syndromes: case report and review of the literature.
Topics: Aging; Antineoplastic Combined Chemotherapy Protocols; Chromosome Banding; Chromosome Deletion; Chromosomes, Human, Pair 15; Chromosomes, Human, Y; Clone Cells; Cyclophosphamide; Humans; In Situ Hybridization, Fluorescence; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Pancytopenia; Trisomy; Tumor Cells, Cultured; Vidarabine | 2003 |
2 trial(s) available for vidarabine and Pancytopenia
Article | Year |
---|---|
Hematopoietic stem cell transplantation for multiply transfused patients with sickle cell disease and thalassemia after low-dose total body irradiation, fludarabine, and rabbit anti-thymocyte globulin.
Topics: Adolescent; Adult; Anemia, Sickle Cell; Antilymphocyte Serum; Child; Combined Modality Therapy; Female; Graft Rejection; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hemoglobinopathies; Humans; Immunosuppressive Agents; Infections; Male; Pancytopenia; Thalassemia; Transfusion Reaction; Transplantation Chimera; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation | 2005 |
Fludarabine, arabinosyl cytosine and idarubicin (FLAI) for remission induction in poor-risk acute myeloid leukemia.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cytarabine; Disease-Free Survival; Female; Humans; Idarubicin; Leukemia, Myeloid; Male; Middle Aged; Pancytopenia; Pilot Projects; Remission Induction; Salvage Therapy; Survival Analysis; Survival Rate; Vidarabine | 2001 |
9 other study(ies) available for vidarabine and Pancytopenia
Article | Year |
---|---|
The impact of bridging therapy prior to CD19-directed chimeric antigen receptor T-cell therapy in patients with large B-cell lymphoma.
Topics: Adrenal Cortex Hormones; Adult; Aged; Antigens, CD19; Antineoplastic Combined Chemotherapy Protocols; Biological Products; Combined Modality Therapy; Cyclophosphamide; Cytokine Release Syndrome; Female; Humans; Immunotherapy, Adoptive; Kaplan-Meier Estimate; Leukapheresis; Lymphocyte Depletion; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Pancytopenia; Progression-Free Survival; Receptors, Antigen, T-Cell; Retrospective Studies; Salvage Therapy; Vidarabine | 2021 |
Retrospective Analysis of Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia Treated with FLAG at a Comprehensive Cancer Center.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cancer Care Facilities; Cytarabine; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasm Recurrence, Local; Pancytopenia; Retrospective Studies; Salvage Therapy; Survival Rate; Vidarabine; Young Adult | 2021 |
Myelosuppression after frontline fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: analysis of persistent and new-onset cytopenia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase II as Topic; Cyclophosphamide; Female; Humans; Immune Tolerance; Immunotherapy; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Myeloablative Agonists; Neoadjuvant Therapy; Pancytopenia; Retrospective Studies; Rituximab; Treatment Outcome; Vidarabine; Young Adult | 2013 |
Efficacy and long-term toxicity of the rituximab-fludarabine-cyclophosphamide combination therapy in Waldenstrom's macroglobulinemia.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cell Transformation, Neoplastic; Cyclophosphamide; Female; Humans; Male; Middle Aged; Pancytopenia; Retrospective Studies; Rituximab; Survival Rate; Treatment Outcome; Vidarabine; Waldenstrom Macroglobulinemia | 2016 |
Autoimmune pancytopenia following combination chemotherapy for chronic lymphocytic leukaemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Autoimmune Diseases; Cyclophosphamide; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Pancytopenia; Vidarabine | 2009 |
The frequency, manifestations, and duration of prolonged cytopenias after first-line fludarabine combination chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Female; Hematologic Diseases; Humans; Leukemia, Lymphoid; Leukopenia; Male; Middle Aged; Neoadjuvant Therapy; Neutropenia; Pancytopenia; Prevalence; Retrospective Studies; Thrombocytopenia; Time Factors; Vidarabine | 2010 |
T cell-depleted allogeneic bone marrow transplantation from a partially HLA-mismatched unrelated donor for progressive chronic lymphocytic leukemia and fludarabine-induced bone marrow failure.
Topics: Antineoplastic Agents; Bone Marrow; Bone Marrow Transplantation; HLA Antigens; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemic Infiltration; Living Donors; Lymphocyte Depletion; Male; Middle Aged; Pancytopenia; T-Lymphocytes; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 1996 |
Fatal myelofibrosis following fludarabine administration in a patient with indolent lymphoma.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fatal Outcome; Humans; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pancytopenia; Prednisone; Primary Myelofibrosis; Vidarabine; Vincristine | 1998 |
Remarkable response to rituximab in a 72-year-old patient with refractory non-Hodgkin's lymphoma and marrow aplasia.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Cyclophosphamide; Humans; Lymph Nodes; Lymphoma, Non-Hodgkin; Male; Pancytopenia; Prednisone; Red-Cell Aplasia, Pure; Rituximab; Treatment Outcome; Vidarabine; Vincristine | 2001 |